全球合成生物学工具市场规模、份额、趋势和成长分析报告（2026-2034）

预计合成生物学工具市场将从 2025 年的 193 亿美元成长到 2034 年的 843.6 亿美元，2026 年至 2034 年的复合年增长率为 17.81%。

随着生物学与工程学的融合推动医疗保健、农业和工业生物技术领域的创新，全球合成生物学工具市场正在迅速扩张。 CRISPR基因编辑系统、DNA合成平台和先进的生物资讯软体等合成生物学工具，能够以前所未有的方式控制生物系统。这些进步正在加速药物研发、作物改良、生质燃料开发和永续化学品生产等领域的应用。

高通量自动化、纠错技术以及成本效益高的基因合成技术的不断改进，正在使合成生物学技术更加普及。云端平台和人工智慧驱动的分析技术的集成，正在简化资料管理并加速设计-建构-测试-学习（DBTL）週期。学术机构和Start-Ups正在加强与行业领导者的合作，以开发具有商业性潜力的新型合成途径和设计生物体。

未来的机会在于可程式设计细胞疗法、用于环境监测的生物感测器以及能够按需进行生物设计的生物铸造厂。随着全球各产业优先考虑永续性和循环生物经济模式，合成生物学工具将在以可再生生物替代方案取代石油基製程方面发挥核心作用。这个市场将继续作为下一代生物技术的基石，并有望在多个领域释放变革性创新。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球合成生物学工具市场：依产品划分

• 市场分析、洞察与预测
• 寡核苷酸/寡核苷酸丛集和合成DNA
• 酵素
• 克隆技术套件
• 异源核酸
• 基本生物

第五章 全球合成生物学工具市场：依技术划分

• 市场分析、洞察与预测
• 次世代定序技术
• PCR技术
• 基因组编辑技术
• 生物加工技术
• 其他技术

第六章 全球合成生物学工具市场：依应用领域划分

• 市场分析、洞察与预测
• 卫生保健
• 除了医疗保健之外

第七章 全球合成生物学工具市场：依最终用途划分

• 市场分析、洞察与预测
• 生物技术和製药公司
• 学术研究机构
• 其他的

第八章 全球合成生物学工具市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Bota Biosciences Inc
  • Codexis Inc
  • Creative Biogene
  • Creative Enzymes
  • Enbiotix Inc
  • Illumina Inc
  • Merck KGaA（Sigma-Aldrich Co. LLC）
  • New England Biolabs
  • Eurofins Scientific
  • Novozymes
  • Pareto Bio Inc

The Synthetic Biology Tools Market size is expected to reach USD 84.36 Billion in 2034 from USD 19.30 Billion (2025) growing at a CAGR of 17.81% during 2026-2034.

The global synthetic biology tools market is expanding rapidly as the convergence of biology and engineering drives innovation across healthcare, agriculture, and industrial biotechnology. Synthetic biology tools such as CRISPR gene-editing systems, DNA synthesis platforms, and advanced bioinformatics software are enabling unprecedented control over biological systems. These advancements are accelerating applications in drug discovery, crop engineering, biofuel development, and sustainable chemical production.

Continuous improvements in high-throughput automation, error-correction methods, and cost-efficient gene synthesis are democratizing access to synthetic biology capabilities. Integration with cloud-based platforms and AI-driven analytics is streamlining data management, facilitating faster design-build-test-learn (DBTL) cycles. Academic institutions and startups are increasingly collaborating with industry leaders to develop novel synthetic pathways and engineered organisms with commercial potential.

Future opportunities lie in programmable cell therapies, biosensors for environmental monitoring, and biofoundries capable of on-demand organism design. As global industries prioritize sustainability and circular bioeconomy models, synthetic biology tools will play a central role in replacing petroleum-based processes with renewable biological alternatives. The market is set to remain a cornerstone of next-generation biotechnology, unlocking transformative innovations across multiple sectors.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Oligonucleotide/Oligo Pools and Synthetic DNA
• Enzymes
• Cloning Technologies Kits
• Xeno-Nucleic Acids
• Chassis Organism

By Technology

• NGS Technology
• PCR Technology
• Genome Editing Technology
• Bioprocessing Technology
• Other Technologies

By Application

• Healthcare
• Non-healthcare

By End Use

• Biotechnology and Pharmaceutical companies
• Academic and Research Institutes
• Others

COMPANIES PROFILED

• Bota Biosciences Inc, Codexis Inc, Creative Biogene, Creative Enzymes, Enbiotix Inc, Illumina Inc, Merck KGaA SigmaAldrich Co LLC, New England Biolabs, Eurofins Scientific, Novozymes, Pareto Bio Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL SYNTHETIC BIOLOGY TOOLS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Oligonucleotide/Oligo Pools and Synthetic DNA Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Enzymes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Cloning Technologies Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Xeno-Nucleic Acids Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Chassis Organism Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SYNTHETIC BIOLOGY TOOLS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. NGS Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. PCR Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Genome Editing Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Bioprocessing Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Other Technologies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SYNTHETIC BIOLOGY TOOLS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Healthcare Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Non-healthcare Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL SYNTHETIC BIOLOGY TOOLS MARKET: BY END USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End Use
• 7.2. Biotechnology and Pharmaceutical companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Academic and Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL SYNTHETIC BIOLOGY TOOLS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Technology
  • 8.2.3 By Application
  • 8.2.4 By End Use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Technology
  • 8.3.3 By Application
  • 8.3.4 By End Use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Technology
  • 8.4.3 By Application
  • 8.4.4 By End Use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Technology
  • 8.5.3 By Application
  • 8.5.4 By End Use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Technology
  • 8.6.3 By Application
  • 8.6.4 By End Use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL SYNTHETIC BIOLOGY TOOLS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Bota Biosciences Inc
  • 10.2.2 Codexis Inc
  • 10.2.3 Creative Biogene
  • 10.2.4 Creative Enzymes
  • 10.2.5 Enbiotix Inc
  • 10.2.6 Illumina Inc
  • 10.2.7 Merck KGaA (Sigma-Aldrich Co. LLC)
  • 10.2.8 New England Biolabs
  • 10.2.9 Eurofins Scientific
  • 10.2.10 Novozymes
  • 10.2.11 Pareto Bio Inc